No Data
Express News | Obi Pharma Announces U.S. FDA Clearance of Ind Application for a Phase 1/2 Study of Obi-902, a Trop-2 Targeting ADC
Roche's Ventana Trop2 W Breakthrough Device Designation From US FDA
Tariff pause sparks optimism, domestic plays and RE seen as safe bets
CK Life Sciences Reports Promising Preclinical Results for TROP2 Cancer Vaccines
Malaysian REITs Likely to See Strong Earnings Growth in 1Q -- Market Talk
Developers Optimistic Property Sales Will Pick Up, Cautious About Rising Costs, Industry Survey Shows
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Trading Interns OP : For more detailed analysis, check out my bio. We analyse followers' stock every weekend.